1. Determination of Anticyclic Citrullinated Peptide Based on Biotin-Streptavidin-Amplified Time-Resolved Fluoroimmunoassay.
- Author
-
Sheng H, Hu ZG, Liu J, Yuan F, Li M, Zou Y, and Chen Y
- Subjects
- Animals, Case-Control Studies, Enzyme-Linked Immunosorbent Assay, Fluoroimmunoassay, Humans, Immunoassay, Limit of Detection, Lupus Erythematosus, Systemic blood, Lupus Erythematosus, Systemic diagnosis, Mixed Connective Tissue Disease blood, Mixed Connective Tissue Disease diagnosis, Multiple Sclerosis blood, Multiple Sclerosis diagnosis, Peptides, Cyclic immunology, Prognosis, Rabbits, Scleroderma, Systemic blood, Scleroderma, Systemic diagnosis, Sjogren's Syndrome blood, Sjogren's Syndrome diagnosis, Antibodies, Anti-Idiotypic blood, Autoantibodies blood, Biotin, Peptides, Cyclic blood, Streptavidin analysis
- Abstract
Background: A rapid and sensitive time-resolved fluoroimmunoassay (TRFIA) based on the biotin-streptavidin amplification system was developed for the determination of anticyclic citrullinated peptide (anti-CCP)., Methods: Europium-labeled streptavidin derivatives combined with europium and anhydride of diethylene triamine pentaacetic acid were used to label streptavidin, biotin was coupled with rabbit anti-human IgG to form a biotin-anti-human IgG bridge between streptavidin-europium and the anti-CCP antibody in the immunoassay. The anti-CCP assay was carried out by measuring the fluorescence of Eu(3+) -streptavidin at 615 nm., Results: The presented method produced a wide linear range from 0.58 to 9,463 U/ml, while it was only 591.4-18.48 U/ml when using an ELISA kit, and featured a detection limit up to 0.5 U/ml for anti-CCP. The values determined by the biotin-streptavidin-TRFIA and ELISA correlated well (R(2) = 0.8927). The method was applied to determine anti-CCP in serum samples with satisfied recoveries of 96.45-104.63%., Conclusion: The assay results obtained by the present method showed that biotin-streptavidin-amplified TRFIA improve the traditional ELISA kit for anti-CCP detection. Therefore, it offers a better alternative immunoassay in rheumatoid arthritis management., (© 2014 Wiley Periodicals, Inc.)
- Published
- 2015
- Full Text
- View/download PDF